Praxis Precision Medicines’ commitment to forging ahead with ulixacaltamide in essential tremor (ET) has paid off. | The ...

Shares of biopharmaceutical company Praxis Precision Medicines Inc. are soaring, boosted by the successful trial of a new ...

Topline data were announced from two phase 3 trials evaluating ulixacaltamide in patients with essential tremor.

Shares of Praxis Precision Medicines more than tripled Thursday, peaking at $200 apiece, after the company disclosed positive ...

Praxis Precision Medicines Inc. (NASDAQ: PRAX) is one of the Reddit stocks that will go to the moon. On October 16, Praxis ...

CND Life Sciences (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and ...

Praxis Precision surges on positive ulixacaltamide data for essential tremor, but tolerability limits impact. Explore PRAX's ...

Praxis Precision Medicines (NASDAQ:PRAX) saw its stock soar 100% on Thursday after announcing strong topline data from two ...

The multicenter, randomized, double-blind, sham-controlled clinical trial evaluated 125 adults with essential tremor across 12 neurology centers in the U.S. and China over 90 days. Key outcomes ...

"It's being open about it [your diagnosis]. Everyone thinks you have Parkinson's and actually, this condition is more common but nobody has heard of it," Ms Wurr said. In the film, Lord Julian ...

Dear Doctors: I think I’m coming down with essential tremors, which run in my family. At age 81, my left hand and left leg are making movements that I’m not initiating. My dad died at 95, and because ...